Abstract submission for ADI 2020 now open!

26 June 2019 – Abstract submission is now open for the 34th International Conference of Alzheimer's Disease International (ADI), to take place in Singapore in March 2020. [read more]

Global Perspective Newsletter for July 2019

The July 2019 edition of our Global Perspective Newsletter is now available. Read the latest news from ADI, our partners and member associations, including updates on the upcoming World Alzheimer's Month, World Alzheimer Report, and much more. [read more]

Novartis, Amgen and Banner Alzheimer's Institute remain committed after discontinuation of two Generation Program studies

11 July 2019 – Novartis, Amgen and Banner Alzheimer's Institute have announced the discontinuation of investigation of the BACE1 inhibitor CNP520 (umibecestat) in two Phase II/III studies. The decision followed the identification of worsening in some measures of cognitive function during a regular pre-planned review of unblinded data; the sponsors concluded that the potential benefit for participants in the studies did not outweigh the risk. [read more]

Dementia and healthy ageing given prominent focus at the G20

4 July 2019 – Dementia was specifically recognised as a global health priority by G20 leaders in the declaration of the Osaka Summit this weekend. ADI worked hard for this to happen and it will provide much needed global attention from G20 countries, as we continue to press governments to respond the healthcare challenges of dementia and to improve the lives of people with living dementia and their families. [read more]

Syndicate content